OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach
- Author
- OROSZI, Gabor1 ; ANTON, Raymond F1 ; O'MALLEY, Stephanie2 ; SWIFT, Robert3 ; PETTINATI, Helen4 ; COUPER, David5 ; QIAOPING YUAN6 ; GOLDMAN, David6
[1] Center for Drug and Alcohol Programs, Medical University of South Carolina, Charleston, South Carolina, United States
[2] Substance Abuse Treatment Unit, Yale University School of Medicine, New Haven, Connecticut, United States
[3] Roger Williams Medical Center and Providence VA Medical Center, Brown University, Providence, Rhode Island, United States
[4] Treatment Research Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
[5] Collaborative Studies Coordinating Center, University of North Carolina, Chapel Hill, North Carolina, United States
[6] Laboratory of Neurogenetics NIAAA, NIH, Rockville, Maryland, United States - Source
Alcoholism, clinical and experimental research. 2009, Vol 33, Num 3, pp 383-393, 11 p ; ref : 1 p.1/4
- CODEN
- ACRSDM
- ISSN
- 0145-6008
- Scientific domain
- Psychology, psychopathology, psychiatry; Toxicology
- Publisher
- Wiley, Hoboken, NJ
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Good Clinical Outcome Haplotype by Medication Interaction Haplotype Naltrexone OPRMI Asn40Asp Treatment Response
- Keyword (fr)
- Antagoniste analgésique narcotique Antialcoolique Efficacité traitement Facteur prédictif Haplotype Naltrexone Pronostic Traitement Dérivé du morphinane
- Keyword (en)
- Narcotic antagonist Antialcohol drug Treatment efficiency Predictive factor Haplotype Naltrexone Prognosis Treatment Morphinan derivatives
- Keyword (es)
- Antagonista narcótico Antialcohólico Eficacia tratamiento Factor predictivo Haplotipo Naltrexona Pronóstico Tratamiento Morphinano derivado
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B03 Toxicology / 002B03F Alcoholism and acute alcohol poisoning
- Discipline
- Toxicology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 21452402
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1111/j.1530-0277.2008.00846.x 
https://dx.doi.org/10.1111/j.1530-0277.2008.00846.x
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Alcoholism, clinical and experimental research\";s:9:\"\u0000*\u0000stitle\";s:23:\"Alcohol. clin. exp. res\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"393\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0145-6008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OROSZI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Gabor\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"ANTON, Raymond F\";i:1;s:19:\"O'MALLEY, Stephanie\";i:2;s:13:\"SWIFT, Robert\";i:3;s:16:\"PETTINATI, Helen\";i:4;s:13:\"COUPER, David\";i:5;s:13:\"QIAOPING YUAN\";i:6;s:14:\"GOLDMAN, David\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACRSDM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Alcoholism, clinical and experimental research\";s:9:\"\u0000*\u0000stitle\";s:23:\"Alcohol. clin. exp. res\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"393\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0145-6008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OROSZI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Gabor\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"ANTON, Raymond F\";i:1;s:19:\"O'MALLEY, Stephanie\";i:2;s:13:\"SWIFT, Robert\";i:3;s:16:\"PETTINATI, Helen\";i:4;s:13:\"COUPER, David\";i:5;s:13:\"QIAOPING YUAN\";i:6;s:14:\"GOLDMAN, David\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACRSDM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Alcoholism, clinical and experimental research\";s:9:\"\u0000*\u0000stitle\";s:23:\"Alcohol. clin. exp. res\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"393\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0145-6008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OROSZI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Gabor\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"ANTON, Raymond F\";i:1;s:19:\"O'MALLEY, Stephanie\";i:2;s:13:\"SWIFT, Robert\";i:3;s:16:\"PETTINATI, Helen\";i:4;s:13:\"COUPER, David\";i:5;s:13:\"QIAOPING YUAN\";i:6;s:14:\"GOLDMAN, David\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACRSDM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Alcoholism, clinical and experimental research\";s:9:\"\u0000*\u0000stitle\";s:23:\"Alcohol. clin. exp. res\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"393\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0145-6008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OROSZI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Gabor\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"ANTON, Raymond F\";i:1;s:19:\"O'MALLEY, Stephanie\";i:2;s:13:\"SWIFT, Robert\";i:3;s:16:\"PETTINATI, Helen\";i:4;s:13:\"COUPER, David\";i:5;s:13:\"QIAOPING YUAN\";i:6;s:14:\"GOLDMAN, David\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACRSDM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:32:\"10.1111\/j.1530-0277.2008.00846.x\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:9:\"\u0000*\u0000jtitle\";s:46:\"Alcoholism, clinical and experimental research\";s:9:\"\u0000*\u0000stitle\";s:23:\"Alcohol. clin. exp. res\";s:7:\"\u0000*\u0000date\";s:4:\"2009\";s:9:\"\u0000*\u0000volume\";s:2:\"33\";s:8:\"\u0000*\u0000issue\";s:1:\"3\";s:8:\"\u0000*\u0000spage\";s:3:\"383\";s:8:\"\u0000*\u0000epage\";s:3:\"393\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0145-6008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"OROSZI\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Gabor\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:7:{i:0;s:16:\"ANTON, Raymond F\";i:1;s:19:\"O'MALLEY, Stephanie\";i:2;s:13:\"SWIFT, Robert\";i:3;s:16:\"PETTINATI, Helen\";i:4;s:13:\"COUPER, David\";i:5;s:13:\"QIAOPING YUAN\";i:6;s:14:\"GOLDMAN, David\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"ACRSDM\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:84:\"OPRM1 Asn40Asp Predicts Response to Naltrexone Treatment: A Haplotype-Based Approach\";s:8:\"\u0000*\u0000place\";s:11:\"Hoboken, NJ\";s:6:\"\u0000*\u0000pub\";s:5:\"Wiley\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
